Diaceutics Share Discussion Threads

[sevenccc] 02/2/2024 14:56

CFO here looks an interesting young chap. Nick Roberts. Left CERES to join Ergomed as number 2 to CFO just before they surged in late 2019/early 2020. Not sure when he left ERGO but has had the leg up to CFO in a smaller business. Hope his track record of picking successful companies continues here.

[chrisdgb] 30/1/2024 07:54

All looking good, on track for my 200p+ takeout eventually......

[chrisdgb] 19/1/2024 08:28

Trading update in just over a week..........

[chrisdgb] 18/12/2023 09:42

As usual very little activity here but hoping for good things in 24'....

[chrisdgb] 17/11/2023 08:15

shares seem well bid at the moment.......

[1c3479z] 26/9/2023 13:28

loads of potential: can it turn a decent profit?

[chrisdgb] 26/9/2023 10:57

'accelerate the corporate development'..........could be interesting

[chrisdgb] 30/8/2023 10:31

Nice to see more interest here....

[chrisdgb] 25/8/2023 07:24

Thanks Martin...........

[hastings] 25/8/2023 07:20

Recently caught up with management, write up for interest.

[chrisdgb] 04/8/2023 08:25

Nice to see they are spreading the word, US crucial.......

[1c3479z] 28/7/2023 20:35

good rise today
management and Directors very well remunerated and other benefits, altogether getting more than the annual profit presently although they would argue the company is early in its growth trajectory....

[1c3479z] 25/7/2023 18:42

wouldn't put it as strongly as that; there's many a company long expected to be taken over yet which has never received a bid...
DXRX value might be in the data lake they hold except ?this is the property of the large pharmas so their real value could be in their client list and lab connections.

[chrisdgb] 25/7/2023 11:35

almost inevitable.......

[1c3479z] 25/7/2023 11:23

might attract takeover interest given its strong market position, cash and connections?

[chrisdgb] 25/7/2023 06:52

Buy it while you can.......

[chrisdgb] 17/7/2023 07:51

Trading update due in the coming days I would say........

[chrisdgb] 22/6/2023 06:47

If it stays at this price, a takeover in the next year looks inevitable........

[chrisdgb] 05/6/2023 07:06

Nice news.........

[chrisdgb] 16/5/2023 08:48

Always struggles to maintain any gains this stock........

[melloteam] 15/5/2023 15:00

Just to let shareholders and prospective investors know that Diaceutics will be presenting on the MelloMonday webinar at 5pm today.

The programme for the evening is as follows:

5.00 pm Mello welcome followed by a Question & Answer session from Sosandar
5.30 pm Company presentation from Diaceutics
6.10 pm Company presentation from WiseAlpha
6.50 pm Mello BASH with Damian Cannon & Kevin Taylor featuring Ten Entertainment Group (TEG) and Barratt Developments (BDEV)

There will be over 500 investors attending and these are very popular shows with company presentations, fund manager and investor interviews, and panel sessions.

Tickets for today's event are FREE so make sure you tune in and take advantage!

[tomps2] 21/4/2023 09:25

Diaceutics (DXRX) Full Year 2022 Results presentation - April 2023

Diaceutics CFO, Nick Roberts & CIO Ryan Keeling present full year results for the period ended 31 December 2022, which shows a strong trading performance with continued momentum driving strategic investment into 2023.

Watch the video here:

Listen to the podcast here:

[kalai1] 17/4/2023 10:33

Diaceutics PLC posted Finals for FY22 this morning titled "Strong trading performance with continued momentum driving strategic investment into 2023." Revenues increased 40% to £19.5 million, a 26% increase on a constant currency basis and materially ahead of initial expectations.Gross profit increased by 37% to £16.7 million, EBITDA was £3.6 million (2021: £2.3 million) with an EBITDA margin of 18%, slightly ahead of the prior year (2021: 17%). The outook is solid with order books up to £16.9 million, while the balance sheet is also strong with cash and cash equivalents of £19.8 million. Valuation looks a little unhelpful with PS ratio at around 5.5x, the share price also lacks positive momentum. DXRX has a solid track record of topline growth but is a share to monitor for the time being...

...from WealthOraacle

[chrisdgb] 17/4/2023 07:18

Business in fine shape, can try tp push back through the 120p level now the banking stuff sorted out....!

[chrisdgb] 13/4/2023 10:20

Bit of nibbling ahead of results, should give us a real handle for the coming months....